E3 Transcription Unit of Adenovirus

  • W. S. M. Wold
  • A. E. Tollefson
  • T. W. Hermiston
Part of the Current Topics in 199/I Microbiology and Immunology book series (CT MICROBIOLOGY, volume 199/1)

Abstract

Mammals have innate and adaptive defenses that protect them from virus infections. Viruses, in particular the large DNA viruses (adenoviruses, herpesviruses, poxviruses), have evolved mechanisms that counteract the host’s antiviral defenses. In general, these viruses prevent killing of infected cells by cytotoxic T lymphocytes (CTL), block the inflammatory response, inhibit complement fixation, prevent shut-off of cellular protein synthesis in response to interferon, and block apoptosis (which may be a host defense against virus infection). Reviews have appeared recently on how some of these proteins function (Gooding 1992; G.L. Smith 1994). Here we will focus on the human adenoviruses, in particular the E3 transcription unit, which appears to be, at least in part, a cassette of genes that functions to counteract the host’s antiviral defenses. Recent reviews on this topic are by Pääbo et al. (1989), Wold and Gooding (1989, 1991), Gooding and Wold (1990), Gooding (1992), and Wold (1993).

Keywords

Hepatitis Codon Cysteine Fractionation Serine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abraham SE, Lobo S, Yaciuk P, Wang H-GHW, Moran E (1993) p300, and p300-associated proteins, are components of TATA-binding protein (TBP) complexes. Oncogene 8: 1639–1647PubMedGoogle Scholar
  2. Ames RS, Holskin B, Mitcho M, Shalloway D, Chen M-J (1990) Induction of sensitivity to the cytotoxic action of tumor necrosis factor alpha by adenovirus E1A is independent of transformation and transcriptional activation. J Virol 64: 4115–4122PubMedGoogle Scholar
  3. Andersson M, Pääbo S, Nilsson T, Peterson PA (1985) Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance, Cell 43: 215–222PubMedGoogle Scholar
  4. Andersson M, McMichael A, Peterson PA (1987) Reduced allorecognition of adenovirus-2 infected cells. J Immunol 138: 3960–3966PubMedGoogle Scholar
  5. Baker CC, Ziff EB (1981) Promoters and heterogeneous 5’ termini of the messenger RNAs of adenovirus serotype 2. J Mol Biol 149: 189–221PubMedGoogle Scholar
  6. Beg AA, Finco TS, Nantermet PV, Baldwin AS (1993) Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of Iκβα: a mechanism for NF-κβ activation. Mol Cell Biol 13: 3301–3310PubMedGoogle Scholar
  7. Beier DC, Cox JH, Vining DR, Cresswell P, Engelhard VH (1994) Association of human class I MHC alleles with the adenovirus E3/19K protein. J Immunol 152: 3862–3872PubMedGoogle Scholar
  8. Berk AJ, Sharp PA (1978) Structure of the adenovirus 2 early mRNAs. Cell 14: 695–711PubMedGoogle Scholar
  9. Berk AJ, Lee F, Harrison T, Williams J, Sharp P (1979) Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs. Cell 17: 935–944PubMedGoogle Scholar
  10. Bernards R, Schrier PI, Houweling A, Bos JL, van der Eb AJ, Zijlstra M, Melief CJM (1983) Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity. Nature 305: 776–779PubMedGoogle Scholar
  11. Beutler B, van Huffel C (1994) Unraveling function in the TNF ligand and receptor families. Science 264: 667–668PubMedGoogle Scholar
  12. Bhat BM, Wold WSM (1985) ATTAAA as well as downstream sequences are required for RNA 3’-end formation in the E3 complex transcription unit of adenovirus. Mol Cell Biol 5: 3183–3193PubMedGoogle Scholar
  13. Bhat BM, Wold WSM (1986a) Genetic analysis of mRNA synthesis in region E3 of adenovirus at different stages of infection by RNA processing mutants. J Virol 60: 54–63PubMedGoogle Scholar
  14. Bhat BM, Wold WSM (1986b) Adenovirus mutants with splice-enhancing mutations in the E3 complex transcription unit are also defective in E3A RNA 3’-end formation. J Virol 57: 1155–1158PubMedGoogle Scholar
  15. Bhat BM, Wold WSM (1987) A small deletion distant from a splice or polyadenylation site dramatically alters pre-mRNA processing in region E3 of adenovirus. J Virol 61: 3938–3945PubMedGoogle Scholar
  16. Bhat BM, Brady HA, Pursley MH, Wold WSM (1986) Deletion mutants that alter differential RNA processing in the E3 complex transcription unit of adenovirus. J Mol Biol 190: 543–557PubMedGoogle Scholar
  17. Binger MH, Flint SJ (1984) Accumulation of early and intermediate mRNA species during subgroup C adenovirus productive infections. Virology 136: 387–403PubMedGoogle Scholar
  18. Brady HA, Wold WSM (1987) Identification of a novel sequence that governs both polyadenylation and alternative splicing in region E3 of adenovirus. Nucleic Acids Res. 15: 9397–9416PubMedGoogle Scholar
  19. Brady HA, Wold WSM (1988) Competition between splicing and polyadenylation reactions determines which adenovirus region E3 mRNAs are synthesized. Mol Cell Biol 8: 3291–3297PubMedGoogle Scholar
  20. Brady HA, Scaria A, Wold WSM (1992) Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus. J Virol 66: 5914–5923PubMedGoogle Scholar
  21. Brandt CD, Kim HW, Vargosko AJ, Jeffries BC, Arrobio JO, Rindge B, Parrott RH, Chanock RM (1969) Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to serologic type and illness syndrome. Am J Epidemiol 90: 484–500PubMedGoogle Scholar
  22. Buckbinder L, Miralles VJ, Reinberg D (1989) TPA can overcome the requirement for E1a and together act synergistically in stimulating expression of the adenovirus E3 promoter. EMBO J 8: 4239–4250PubMedGoogle Scholar
  23. Burgert H-G, Kvist S (1985) An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41: 987–997PubMedGoogle Scholar
  24. Burgert H-G, Kvist S (1987) The E3/19K protein of adenovirus type 2 binds to the domains of histocompatibility antigens required for CTL recognition. EMBO J 6: 2019–2026PubMedGoogle Scholar
  25. Burgert H-G, Maryanski JL, Kvist S (1987) “E3/19K” protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens. Proc Natl Acad Sci USA 84: 1356–1360PubMedGoogle Scholar
  26. Carlin CR, Tollefson AE, Brady HA, Hoffman BL, Wold WSM (1989) Epidermal growth factor receptor is down-regulated by a 10,400 MW protein encoded bythe E3 region of adenovirus. Cell 57:135–144PubMedGoogle Scholar
  27. Chang DJ, Ringold GM, Heller RA (1992) Cell killing and induction of manganous superoxide dismutase by tumor necrosis factor-α is mediated by lipoxygenase metabolites of arachidonic acid. Biochem Biophys Res Commun 188: 538–546PubMedGoogle Scholar
  28. Chen M-J, Holskin B, Strickler J, Gorniak J, Clark MA, Johnson PJ, Mitcho M, Shalloway D (1987) Induction by E/A oncogene expression of cellular susceptibility to lysis by TNF. Nature 330: 581–583PubMedGoogle Scholar
  29. Chow LT, Broker TR (1978) The spliced structures of adenovirus 2 fiber message and the other late mRNAs. Cell 15: 497–510PubMedGoogle Scholar
  30. Chow LT, Roberts JM, Lewis JB, Broker TR (1977) A map of cytoplasmic RNA transcripts from lytic adenovirus type 2, determined by electron microscopy of RNA:DNA hybrids. Cell 11: 819–836PubMedGoogle Scholar
  31. Chow LT, Lewis JB, Borker TR (1979a) RNA transcription and splicing at early and intermediate times after adenovirus-2 infection. Cold Spring Harbor Symp Quant Biol 44: 401–414Google Scholar
  32. Chow LT, Broker TR, Lewis JB (1979b) Complex splicing patterns of RNAs from the early regions of adenovirus-2. J Mol Biol 134: 265–303PubMedGoogle Scholar
  33. Cladaras C, Wold WSM (1985) DNA sequence of the early E3 transcription unit of adenovirus 5. Virology 140: 28–43PubMedGoogle Scholar
  34. Cladaras C, Bhat BM, Wold WSM (1985) Mapping the 5’ends, 3’ ends, and splice sites of mRNAs from the E3 transcription unit of adenovirus 5. Virology 140: 44–54PubMedGoogle Scholar
  35. Clark JD, Lin L-L, Kriz RW, Ramesha CS, Sultzman LA, Lin AY, Milona N, Knopf JL (1991) A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP. Cell 65: 1043–1051PubMedGoogle Scholar
  36. Cousin C, Winter N, Gomes SA, D’Halluin JC (1991) Cellular transformation of E1 genes of enteric adenoviruses. Virology 181: 277–287PubMedGoogle Scholar
  37. Cox JH, Yewdell JW, Eisenlohr LC, Johnson PR, Bennink JR (1990) Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Science 247: 715–718PubMedGoogle Scholar
  38. Cox JH, Bennink JR, Yewdell JW (1991) Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation. J Exp Med 174: 1629–1637PubMedGoogle Scholar
  39. Dahllöf B, Wallin M, Kvist S (1991) The endoplasmic reticulum retention signal of the E3/19K protein of adenovirus-2 is microtubule binding. J Biol Chem 266: 1804–1808PubMedGoogle Scholar
  40. Davison AJ, Telford AR, Watson MS, McBride K, Mautner V (1993) The DNA sequence of adenovirus type 40. J Mol Biol 234: 1308–1316PubMedGoogle Scholar
  41. Dbaibo GS, Obeid LM, Hannun YA (1993) Tumor necrosis factor-a (TNF-a) signal transduction through ceramide. J Biol Chem 268: 17762–17766PubMedGoogle Scholar
  42. Dérijard B, Hibi M, Wu l-H, Barrett T, Su B, Deng T, Karin M, Davis RJ (1994) JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76: 1025–1037PubMedGoogle Scholar
  43. Deutscher SL, Bhat BM, Pursley MH, Cladaras C, Wold WSM (1985) Novel deletion mutants that enhance a distant upstream 5’ splice in the E3 transcription unit of adenovirus 2. Nucleic Acids Res 13: 5771–5788PubMedGoogle Scholar
  44. Dobrowsky RT, Kamibayashi C, Mumby MC, Hannun YA (1993) Ceramide activates heterotrimeric protein phosphatase2A. J Biol Chem 268: 15523–15530PubMedGoogle Scholar
  45. Duerksen-Hughes P, Wold WSM, Gooding LR (1989) Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor. J Immunol 143: 4193–4200PubMedGoogle Scholar
  46. Duerksen-Hughes PJ, Hermiston TW, Wold WSM, Gooding LR (1991) The amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cells. J Virol 65: 1236–1244PubMedGoogle Scholar
  47. Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, Lawrence JB, Livingston DM (1994) Molecular cloning and functional analysis of the adenovirus E1 A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev 8: 869–884PubMedGoogle Scholar
  48. Flomenberg PR, Chen M, Horwitz MS (1987) Characterization of a major histocompatibility complex class I antigen-binding glycoprotein from adenovirus type 35, a type associated with immunocompromised hosts. J Virol 61: 3665–3671PubMedGoogle Scholar
  49. Flomenberg PR, Chen M, Horwitz MS (1988) Sequence and genetic organization of adenovirus type 35 early region 3. J Virol 62: 4431–4437PubMedGoogle Scholar
  50. Flomenberg P, Szmulewicz J, Gutierrez E, Lupatkin H (1992) Role of the adenovirus E3–19K conserved region in binding major histocompatibility complex class I molecules. J Virol 66: 4778–4783PubMedGoogle Scholar
  51. Fox JP, Hall CE, Cooney MK (1977) The Seattle virus watch: observations of adenovirus infections. Am J Epidemiol 105: 362–386PubMedGoogle Scholar
  52. Friedman DJ, Ricciardi RP (1988) Adenovirus type 12 E1A gene represses accumulation of MHC class I mRNAs at the level of transcription. Virology 165: 303–305PubMedGoogle Scholar
  53. Gabathuler R, Levy F, Kvist S (1990) Requirements for the association of adenovirus type 2 E3/19K wild-type and mutant proteins with HLA antigens. J Virol 64: 3679–3685PubMedGoogle Scholar
  54. Garcia J, Wu F, Gaynor R (1987) Upstream regulatory regions required to stabilize binding to the TATA sequence in an adenovirus early promoter. Nucleic Acids Res 15: 8367–8385PubMedGoogle Scholar
  55. Ginsberg HS, Lundholm-Beauchamp U, Horswood RL, Pernis B, Wold WSM, Chanock RM, Prince GA (1989) Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc Natl Acad Sci USA 86: 3823–3827PubMedGoogle Scholar
  56. Gooding LR (1992) Virus proteins that counteract hose immune defenses. Cell 71: 5–7PubMedGoogle Scholar
  57. Gooding LR, Wold WSM (1990) Molecular mechanisms by which adenovirus counteract antiviral immune defenses. CRC Crit Rev Immunol 10: 53–71Google Scholar
  58. Gooding LR, Elmore LW, Tollefson AE, Brady HA, Wold WSM (1988) A14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell 53: 341–346PubMedGoogle Scholar
  59. Gooding LR, Sofola IO, Tollefson AE, Duerksen-Hughes P, Wold WSM (1990) The adenovirus E3–14. 7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis. J Immunol 145: 3080–3086PubMedGoogle Scholar
  60. Gooding LR, Aquino L, Duerksen-Hughes PJ, Day D, Horton TM, Yei S, Wold WSM (1991a) The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells. J Virol 65: 3083–3094PubMedGoogle Scholar
  61. Gooding LR, Ranheim TS, Tollefson AE, Aquino L, Duerksen-Hughes P, Horton TM, Wold WSM (1991 b) The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor. J Virol 65: 4114–4123PubMedGoogle Scholar
  62. Grunhaus A, Horwitz MS (1992) Adenoviruses as cloning vectors. Semin Virol 3: 237–252Google Scholar
  63. Grunhaus A, Cho S, Horwitz MS (1994) Association of vaccinia virus-expressed adenovirus E3–19K glycoprotein with class I MHC and its effects on virulence in a murine pneumonia model. Virology 200: 535–546PubMedGoogle Scholar
  64. Hannun YA (1994) The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269: 3125–3128PubMedGoogle Scholar
  65. Hannun YA, Bell RM (1993) The sphingomyelin cycle: a prototypic sphingolipid signaling pathway. Adv Lipid Res 25: 27–41PubMedGoogle Scholar
  66. Hashimoto S, Ishii A, Yonehara S (1991) The E1 b oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas antibody. Int Immunol 3: 343–351PubMedGoogle Scholar
  67. Hawkins LK, Wold WSM (1992) A12,500 MW protein is coded by region E3 of adenovirus. Virology 188: 486–494PubMedGoogle Scholar
  68. Hawkins LK, Wold WSM (1995) A 20 500-dalton protein is coded by region E3 of subgroup B but not subgroup C human adenoviruses. Virology (in press)Google Scholar
  69. Hawkins LK, Wilson-Rawls J, Wold WSM (1995) Region E3 of subgroup B human adenoviruses encodes a 16,000 MW membrane protein that may be a distant analog of the E3–6.7K protein of subgroup C adenoviruses. J Virol (in press)Google Scholar
  70. Hayakawa M, Ishida N, Takeuchi K, Shibamoto S, Hori T, Oku N, Ito F, Tsujimoto M (1993) Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J Biol Chem 268: 11290–11295PubMedGoogle Scholar
  71. Hérissé J, Galibert F (1981) Nucleotide sequence of the EcoRI E fragment of adenovirus 2 genome. Nucleic Acids Res 9: 1229–1240PubMedGoogle Scholar
  72. Hérissé J, Courtois G, Galibert F (1980) Nucleotide sequence of the EcoRI D fragment of adenovirus 2 genome. Nucleic Acids Res 8: 2173–2192PubMedGoogle Scholar
  73. Hennet T, Ziltener HJ, Frei K, Peterhans E (1992) A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J Immunol 149: 932–939PubMedGoogle Scholar
  74. Hermiston TW, Hellwig R, Hierholzer JC, Wold WSM (1993a) Sequence and functional analysis of the human adenovirus type 7 E3-gp19K protein from 17 clinical isolates. Virology 197: 593–600PubMedGoogle Scholar
  75. Hermiston TW, Tripp RA, Sparer T, Gooding LR, Wold WSM (1993b) Deletion mutant analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes. J Virol 67: 5289–5298PubMedGoogle Scholar
  76. Hermiston TW, Tollefson AE, Bhat BM, Skdheer S, Davis A, Hung P, Wold WSM. DNA sequence of the E3 transcription unit of human adenovirus type 4 (manuscript in preparation)Google Scholar
  77. Hoeck WG, Ramesha CS, Chang DJ, Fan N, Heller RA (1993) Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis. Proc Natl Acad Sci USA 90: 4475–4479PubMedGoogle Scholar
  78. Hoffman P, Yaffe MB, Hoffman BL, Yei SP, Wold WSM, Carlin C (1992) Characterization of the adenovirus E3 protein that down-regulates the epidermal growth factor receptor. J Biol Chem 267: 13480–13487PubMedGoogle Scholar
  79. Hong JS, Mullis KG, Engler JA (1988) Characterization of the early region 3 and fiber genes of Ad7. Virology 167: 545–553PubMedGoogle Scholar
  80. Horton TM, Tollefson AE, Wold WSM, Gooding LR (1990) A protein serologically and functionally related to the group C E3 14,700-kilodalton protein is found in multiple adenovirus serotypes. J Virol 64: 1250–1255PubMedGoogle Scholar
  81. Horton TM, Ranheim TS, Aquino L, Kusher Dl, Saha SK, Ware CF, Wold WSM, Gooding LR (1991) Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis. J Virol 65: 2629–2639PubMedGoogle Scholar
  82. Horwitz MS (1990) Adenovirus. In: Fields BN, Knipe DM (eds) Virology, 2nd edn. Raven, New York, pp 1679–1721Google Scholar
  83. Hurst HC, Jones NC (1987) Identification of factors that interact with the E1A-inducible adenovirus E3 promoter. Genes Dev 1: 1132–1146PubMedGoogle Scholar
  84. Jackson MR, Nilsson T, Peterson PA (1990) Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J 9: 3153–3162PubMedGoogle Scholar
  85. Jackson MR, Nifsson T, Peterson PA (1993) Retrieval of transmembrane proteins to the endoplasmic reticulum. J Cell Biol 121: 317–333PubMedGoogle Scholar
  86. Jarvis WD, Kolesnick RN, Fornari FA, Traylor RS, Gewirtz DA, Grant S (1994) Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci USA 91: 73–77PubMedGoogle Scholar
  87. Jefferies WA, Burgert H-G (1990) E3/19K from adenovirus 2 is an immunosubversive protein that binds to a structural motif regulating the intracellular transport of major histocompatibility complex class I proteins. J Exp Med 172: 1653–1664PubMedGoogle Scholar
  88. Johnson DG, Schwarz JK, Cress WD, Nevins JR (1993) Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365: 349–352PubMedGoogle Scholar
  89. Jones N, Shenk T (1979) Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 17: 683–689PubMedGoogle Scholar
  90. Joseph CK, Byun H-S, Bittman R, Kolesnick RN (1993) Substrate recognition by ceramide-activated protein kinase. J Biol Chem 268: 20002–20006PubMedGoogle Scholar
  91. Kämpe O, Beilgrau D, Hammerling U, Lind P, Pääbo S, Severinsson L, Peterson PA (1983) Complex formation of class I transplantation antigens and a viral glycoprotein. J Biol Chem 258:10594–10598PubMedGoogle Scholar
  92. Kapoor QS, Wold WSM, Chinnadurai G (1981) A non-essential glycoprotein is coded by early region E3 of adenovirus type 7. Virology 112: 780–784PubMedGoogle Scholar
  93. Kelly Jr TJ, Lewis Jr AM (1973) Use of nondefective adenovirus-simian virus 40 hybrids for mapping the simian virus 40 genome. J Virol 12: 643–652PubMedGoogle Scholar
  94. Kitchingman GR, Westphal H (1980) The structure of adenovirus 2 early nuclear and cytoplasmic RNAs. J Mol Biol 137: 23–48PubMedGoogle Scholar
  95. Kolesnick R, Golde DW (1994) The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77: 325–328PubMedGoogle Scholar
  96. Körner H, Burgert H-G (1994) Down-regulation of HLA antigens by the adenovirus type 2 E3/19K protein in a T-lymphoma cell line. J Virol 68: 1442–1448PubMedGoogle Scholar
  97. Körner H, Fritzsche U, Burgert H-G (1992) Tumor necrosis factor a stimulates expression of adenovirus early region 3 proteins: implications for viral persistence. Proc Natl Acad Sci USA 89: 11857–11861PubMedGoogle Scholar
  98. Kornfeld R, Wold WSM (1981) Structures of the oligosaccharides of the glycoprotein coded by early region E3 of adenovirus 2. J Virol 40: 440–449PubMedGoogle Scholar
  99. Kornuc M, Kliewer S, Garcia J, Harrich D, Li C, Gaynor R (1990) Adenovirus early region 3 promoter regulation by E1 A/E1B is independent of alterations in DNA binding and gene activation of CREB/ATF and AP1. J Virol 64: 2004–2013PubMedGoogle Scholar
  100. Kozak M (1987) An analysis of 5’-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 15: 8125–8132PubMedGoogle Scholar
  101. Krajcsi P, Wold WSM (1992) The adenovirus E3–14.5K protein which is required for prevention of TNF cytolysis and for down-regulation of the EGF receptor contains phosphoserine. Virology 187: 492–498PubMedGoogle Scholar
  102. Krajcsi P, Tollefson AE, Anderson CW, Stewart AR, Carlin CR, Wold WSM (1992a) The E3–10.4K protein of adenovirus is an integral membrane protein that is partially cleaved between Ala22 and Ala23 and has a Ccyt orientation. Virology 187: 131–144PubMedGoogle Scholar
  103. Krajcsi P, Tollefson AE, Anderson CW, Wold WSM (1992b) The adenovirus E3 14.5-kilodalton protein, which is required for down-regulation of the epidermal growth factor receptor and prevention of tumor necrosis factor cytolysis, is an integral membrane protein oriented with its C terminus in the cytoplasm. J Virol 66: 1665–1673PubMedGoogle Scholar
  104. Krajcsi P, Tollefson AE, Wold WSM (1992c) The E3–14.5K integral membrane protein of adenovirus that is required for down-regulation of the EGF receptor and for prevention of TNF cytolysis is O-glycosy- lated but not N-glycosylated. Virology 188: 570–579PubMedGoogle Scholar
  105. Krönke M, Schütze S, Scheurich P, Pfizenmaier K (1992) TNF signal transduction and TNF-responsive genes. Immunol Ser 56: 189–216PubMedGoogle Scholar
  106. Kuivinen E, Hoffman BL, Hoffman PA, Carlin CR (1993) Structurally related class I and Class II receptor protein tyrosine kinases are down-regulated by the same E3 protein coded for by human group C adenoviruses. J Cell Biol 120: 1271–1279PubMedGoogle Scholar
  107. Kvist S, Ostberg L, Persson H, Philipson L, Peterson PA (1978) Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line. Proc Natl Acad Sci USA 75: 5674–5678PubMedGoogle Scholar
  108. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369: 156–160PubMedGoogle Scholar
  109. Lane JR, Neumann DA, Lafond-Walker A, Herskowitz A, Rose NR (1992) Interleukin 1 or tumor necrosis factor can promote coxsackie B3-induced myocarditis in resistant B10.A mice. J Exp Med 175: 1123–1129PubMedGoogle Scholar
  110. Laster SM, Wood JG, Gooding LR (1988) Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J Immunol 141: 2629–2634PubMedGoogle Scholar
  111. Lavery DJ, Fu SM, Lufkin T, Chen-Kiang S (1987) Productive infection of cultured human lymphoid cells by adenovirus. J Virol 61: 1466–1472PubMedGoogle Scholar
  112. Lin L-L, Lin AY, Knopf JL (1992) Cytosolic phospholipase A2 is coupled to hormonally regulated release of arachidonic acid. Proc Natl Acad Sci USA 89: 6147–6151PubMedGoogle Scholar
  113. Lin L-L, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ (1993) cPLA2 is phosphorylated and activated by MAP kinase. Cell 72: 269–278PubMedGoogle Scholar
  114. Lippé R, Luke E, Kuah YT, Lomas C, Jefferies WA (1991) Adenovirus infection inhibits the phosphorylation of major histocompatibility complex class I proteins. J Exp Med 174: 1159–1166PubMedGoogle Scholar
  115. Liu J, Mathias S, Yang Z, Kolesnick RN (1994) Renaturation and tumor necrosis factor-a stimulation of a 97-kDa ceramide-activated protein kinase. J Biol Chem 269: 3047–3052PubMedGoogle Scholar
  116. Machleidt T, Wiegmann K, Henkel T, Schütze S, Baeuerle P, Krönke M (1994) Sphingomyelinase activates proteolytic Iκβ-α degradation in a cell-free system. J Biol Chem 269: 13760–13765PubMedGoogle Scholar
  117. Mathias S, Kolesnick R (1993) Ceramide: a novel second messenger. Adv Lipid Res 25: 65–90PubMedGoogle Scholar
  118. Matsuse T, Hayashi S, Kuwano K, Keunecke H, Jefferies WA, Hogg JC (1992) Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis 146: 177–184PubMedGoogle Scholar
  119. Mayer A, Gelderblom H, Kümel G, Jungwirth C (1992) Interferon-γ-induced assembly block in the replication cycle of adenovirus 2: augmentation by tumor necrosis factor-a. Virology 187: 372–376PubMedGoogle Scholar
  120. Mei Y-F, Wadell G (1992) The nucleotide sequence of adenovirus type 11 early 3 region: comparison of genome type Ad11 p and Ad11 a. Virology 191: 125–133PubMedGoogle Scholar
  121. Mei Y-F, Wadell G (1993) Hemagglutination properties and nucleotide sequence analysis of the fiber gene of adenovirus genome types 11 p and 11a. Virology 194: 453–462PubMedGoogle Scholar
  122. Mestan J, Digel W, Mittnacht S, Hillen H, Blohm D, Möller A, Jacobsen H, Kirchner H (1986) Antiviral effects of recombinant tumour necrosis factor in vitro. Nature 323: 816–819PubMedGoogle Scholar
  123. Moran E (1993) Interaction of adenoviral proteins with pRB and p53. FASEB J 7: 880–885PubMedGoogle Scholar
  124. Morin JE, Lubeck MD, Barton JE, Conley AJ, Davis AR, Hung PP (1987) Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters. Proc Natl Acad Sci USA 84: 4626–4630PubMedGoogle Scholar
  125. Nevins JR (1992) E2F: a link between the Rb tumor supressor protein and viral oncoproteins. Science 258: 424–429PubMedGoogle Scholar
  126. Nevins JR, Ginsberg HS, Blanchard J-M, Wilson MC, Darnell Jr JE (1979) Regulation of the primary expression of the early adenovirus transcription units. J Virol 32: 727–733PubMedGoogle Scholar
  127. Nilsson T, Jackson M, Peterson PA (1989) Short cytoplasmic sequences serve as retention signals for transmembrane proteins in the endoplasmic reticulum. Cell 58: 707–718PubMedGoogle Scholar
  128. Obeid LM, Linardic CM, Karolak LA, Hannun YA (1993) Programmed cell death induced by ceramide. Science 259: 1769–1771PubMedGoogle Scholar
  129. Ozawa K, Hagiwara H, Tang X, Saka F, Kitabayashi I, Shiroki K, Fujinaga K, Israël A, Gachelin G, Yokoyama K (1993) Negative regulation of the gene for H-2Kb class I antigen by adenovirus 12-E1A is mediated by a CAA repeated element. J Biol Chem 268: 27258–27268PubMedGoogle Scholar
  130. Pääbo S, Weber F, Kämpe O, Schaffner W, Peterson PA (1983) Association between transplantation antigens and a viral membrane protein synthesized from a mammalian expression vector. Cell 35: 445–453Google Scholar
  131. Pääbo S, Nilsson T, Peterson PA (1986a) Adenoviruses of subgenera B, C, D, and E modulate cell- surface expression of major histocompatibility complex class I antigens. Proc Natl Acad Sci USA 83: 9665–9669PubMedGoogle Scholar
  132. Pääbo S, Weber F, Nilsson T, Schaffner W, Peterson PA (1986b) Structural and functional dissection of an MHC class I antigen-binding adenovirus glycoprotein. EMBO J 5:1921–1927PubMedGoogle Scholar
  133. Pääbo S, Bhat BM, Wold WSM, Peterson PA (1987) A short sequence in the COOH terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum. Cell 50: 311–317PubMedGoogle Scholar
  134. Pääbo S, Severinsson L, Andersson M, Martens I, Nilsson T, Peterson PA (1989) Adenovirus proteins and MHC expression. Adv Cancer Res 52: 151–163PubMedGoogle Scholar
  135. Paya CV, Kenmotsu N, Schoon RA, Leibson PJ (1988) Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity. J Immunol 141: 1989–1995PubMedGoogle Scholar
  136. Persson H, Öberg B, Philipson L (1978) Purification and characterization of an early protein (E14K) from adenovirus type 2-infected cells. J Virol 28: 119–139PubMedGoogle Scholar
  137. Persson H, Signäs C, Philipson L (1979) Purification and characterization of an early glycoprotein from adenovirus type 2-infected cells. J Virol 29: 938–948PubMedGoogle Scholar
  138. Persson H, Jansson M, Philipson L (1980a) Synthesis and genomic site for an adenovirus type 2 early glycoprotein. J Mol Biol 136: 375–394PubMedGoogle Scholar
  139. Persson H, Jornväll H, Zabielski J (1980b) Multiple mRNA species for the precursor to an adenovirus- encoded glycoprotein: identification and structure of the signal sequence. Proc Natl Acad Sci USA 77: 6349–6353PubMedGoogle Scholar
  140. Raines MA, Kolesnick RN, Golde DW (1993) Sphingomyelinase and ceramide activate mitogen- activated protein kinase in myeloid HL-60 cells. J Biol Chem 268: 14572–14575PubMedGoogle Scholar
  141. Rammensee H-G, Falk K, Rötzschke O (1993) Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 11: 213–244PubMedGoogle Scholar
  142. Ranheim TS, Shisler J, Horton TM, Wold LJ, Gooding LR, Wold WSM (1993) Characterization of mutants within the gene for the adenovirus E3 14.7-kilodalton protein which prevents cytolysis by tumor necrosis factor. J Virol 67: 2159–2167PubMedGoogle Scholar
  143. Rawle FC, Tollefson AE, Wold WSM, Gooding LR (1989) Mouse anti-adenovirus cytotoxic T lymphocytes. Inhibition of lysis by E3 gp19K but not E3 14.7K. J Immunol 143: 2031–2037PubMedGoogle Scholar
  144. Rawle FC, Knowles BB, Ricciardi RP, Brahmacheri V, Duerksen-Hughes P, Wold WSM (1991) Specificity of the mouse cytotoxic T lymphocyte response to adenovirus 5. E1 A is immunodominant in H-2b, but not in H-2d or H-2k mice. J Immunol 146: 3977–3984PubMedGoogle Scholar
  145. Roberts RJ, Akusjärvi G, Aleström P, Gelinas RE, Gingeras TR, Sciaky D, Pettersson U (1986) A consensus sequence for the adenovirus-2 genome. In: Doerfler WE (ed) Adenovirus DNA, the viral genome and its expression. Nijhoff, Boston, pp 1–51Google Scholar
  146. Ross S, Levine AJ (1979) The genomic map position of the adenovirus type 2 glycoprotein. Virology 99: 427–430PubMedGoogle Scholar
  147. Routes JM, Metz BA, Cook JL (1993) Endogenous expression of E1A in human cells enhances the effect of adenovirus E3 on class I major histocompatibility complex antigen expression. J Virol 67: 3176–3181PubMedGoogle Scholar
  148. Scaria A, Wold WSM (1994) Fine-mapping of sequences that suppress splicing in the E3 complex transcription unit of adenovirus. Virology 205: 406–416PubMedGoogle Scholar
  149. Scaria A, Tollefson AE, Saha SK, Wold WSM (1992) The E3–11.6K protein of adenovirus is an Asn-glyco- sylated integral membrane protein that localizes to the nuclear membrane. Virology 191: 743–753PubMedGoogle Scholar
  150. Schütze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Krönke M (1992) TNF activates NF-kB by phosphatidylcholine-specific phospholipase C-induced “acidic” sphingomyelin breakdown. Cell 71: 765–776PubMedGoogle Scholar
  151. Schrier PI, Bernards R, Vaessen RTMJ, Houweling A, van der Eb AJ (1983) Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature 305: 771–775PubMedGoogle Scholar
  152. Severinsson L, Martens I, Peterson PA (1986) Differential association between two human MHC class I antigens and an adenoviral glycoprotein. J Immunol 137: 1003–1009PubMedGoogle Scholar
  153. Shaw AR, Ziff EB (1980) Transcripts from the adenovirus-2 major late promoter yield a single early family of 3’ coterminal mRNAs and five late families. Cell 22: 905–916PubMedGoogle Scholar
  154. Shemesh J, Rotem-Yehudar R, Ehrlich R (1991) Transcriptional and postranscriptional regulation of class I major histocompatibility complex genes following transformation with human adenoviruses. J Virol 65: 5544–5548PubMedGoogle Scholar
  155. Signäs C, Katze MG, Persson H, Philipson L (1982) An adenovirus glycoprotein binds heavy chains of class I transplantation antigens from man and mouse. Nature 299: 175–178PubMedGoogle Scholar
  156. Signäs C, Akusjärvi G, Pettersson U (1986) Region E3 of human adenoviruses; differences between the oncogenic adenovirus-3 and the non-oncogenic adenovirus-2. Gene 50: 173–184PubMedGoogle Scholar
  157. Silver J, Anderson CW (1988) Interaction of human adenovirus serotype 2 with human lymphoid cells. Virology 165: 377–387PubMedGoogle Scholar
  158. Smith CA, Farrah T, Goodwin RG (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76: 959–962PubMedGoogle Scholar
  159. Smith GL (1994) Virus strategies for evasion of the host response to infection. Trends Microbiol 2: 81–88PubMedGoogle Scholar
  160. Sprengel J, Schmitz B, Heuss-Neitzel D, Zock C, Doerfler W (1994) Nucleotide sequence of human adenovirus type 12 DNA: comparative functional analysis. J Virol 68: 379–389PubMedGoogle Scholar
  161. Stålhandske P, Persson H, Perrieaudet M, Philipson L, Pettersson U (1983) Structure of three spliced mRNAs from region E3 of adenovirus type 2. Gene 22: 157–165PubMedGoogle Scholar
  162. Stein R, Ziff EB (1984) HeLa cell beta-tubulin gene transcription is stimulated by adenovirus 5 in parallel with viral early genes by an E1a-dependent mechanism. Mol Cell Biol 4: 2792–2801PubMedGoogle Scholar
  163. Stewart AR, Tollefson AE, Krajcsi P, Yei S-P, Wold WSM (1995) The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to downregulate the epidermal growth factor receptor, are localized in the plasma membrane. J Virol 69: 172–181PubMedGoogle Scholar
  164. Suffys P, Beyaert R, DeValck D, Vanhaesebroeck B, Van Roy F, Fiers W (1991) Tumour-necrosis-factor- mediated cytotoxicity is correlated with phospholipase-A2 activity, but not with arachidonic acid release per se. Eur J Biochem 195: 465–475PubMedGoogle Scholar
  165. Tanaka Y, Tevethia SS (1988) Differential effect of adenovirus 2 E3/19K glycoprotein on the expression of H-2Kb and H-2Db class I antigens and H-2Kb-and H-2Db-restricted SV40-specific CTL-mediated lysis. Virology 165: 357–366PubMedGoogle Scholar
  166. Tartaglia LA, Ayres TM, Wong GHW, Goeddel DV (1993) A novel domain within the 55 kd TNF receptor signals cell death. Cell 74: 845–853PubMedGoogle Scholar
  167. Tollefson AE, Wold WSM (1988) Identification and gene mapping of a 14,700-molecular-weight protein encoded by region E3 of group C adenoviruses. J Virol 62: 33–39PubMedGoogle Scholar
  168. Tollefson AE, Krajcsi P, Pursley MH, Gooding LR, Wold WSM (1990a) A 14,500 MW protein is coded by region E3 of group C human adenoviruses. Virology 175: 19–29PubMedGoogle Scholar
  169. Tollefson AE, Krajcsi P, Yei S, Carlin CR, Wold WSM (1990b) A 10,400-molecular-weight membrane protein is coded by region E3 of adenovirus. J Virol 64: 794–801PubMedGoogle Scholar
  170. Tollefson AE, Stewart AR, Yei S, Saha SK, Wold WSM (1991) The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor. J Virol 65: 3095–3105PubMedGoogle Scholar
  171. Tollefson AE, Scaria A, Saha SK, Wold WSM (1992) The 11,600-Mw protein encoded by region E3 of adenovirus is expressed early but is greatly amplified at late stages of infection. J Virol 66: 3633–3642PubMedGoogle Scholar
  172. Tufariello J, Cho S, Horwitz MS (1994) The adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model. J Virol 68: 453–462PubMedGoogle Scholar
  173. Uhlen M, Svensson C, Josephson S, Aleström P, Chattapadhyaya JB, Pettersson U, Philipson L (1982) Leader arrangement in the adenovirus fiber mRNA. EMBO J 1: 249–254PubMedGoogle Scholar
  174. Van Lint J, Agostinis P, Vandevoorde V, Haegeman G, Fiers W, Merlevede W, Vandenheede JR (1992) Tumor necrosis factor stimulates multiple serine/threonine protein kinases in Swiss 3T3 and L929 cells. J Biol Chem 267: 25916–25921PubMedGoogle Scholar
  175. Vasavada R, Eager KB, Barbanti-Brodano G, Caputo A, Ricciardi RP (1986) Adenovirus type 12 early region 1A proteins repress class I HLA expression in transformed human cells. Proc Natl Acad Sci USA 83: 5257–5261PubMedGoogle Scholar
  176. Vassalli P (1992) The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10: 411–452PubMedGoogle Scholar
  177. Vietor I, Schwenger P, Li W, Schlessinger J, Vilcek J (1993) Tumor necrosis factor-induced activation and increased tyrosine phosphorylation of mitogen-activated protein (MAP) kinase in human fibroblasts. J Biol Chem 268: 18994–18999PubMedGoogle Scholar
  178. Vilcek J, Lee TH (1991) Tumor necrosis factor. J Biol Chem 266: 7313–7316PubMedGoogle Scholar
  179. Wang EW, Scott MO, Ricciardi RP (1988) An adenovirus mRNA which encodes a 14,700-Mr protein that maps to the last open reading frame in region E3 is expressed during infection. J Virol 62:1456–1459PubMedGoogle Scholar
  180. White E, Cipriani R (1989) Specific disruption of intermediate filaments and the nuclear lamina by the 19-kDa product of the adenovirus E1 B oncogene. Proc Natl Acad Sci USA 86: 9886–9890PubMedGoogle Scholar
  181. White E, Cipriani R (1990) Role of adenovirus E1B proteins in transformation: altered organization of intermediate filaments in transformed cells that express the 19-kilodalton protein. Mol Cell Biol 10: 120–130PubMedGoogle Scholar
  182. White E, Sabbatini P, Debbas M, Wold WSM, Kusher Dl, Gooding LR (1992) The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor α. Mol Cell Biol 12: 2570–2580PubMedGoogle Scholar
  183. Wiegmann K, Schütze S, Kampen E, Himmler A, Machleidt T, Kränke M (1992) Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades. J Biol Chem 267: 17997–18001PubMedGoogle Scholar
  184. Williams JL, Garcia J, Harrich D, Pearson L, Wu F, Gaynor R (1990) Lymphoid specific gene expression of the adenovirus early region 3 promoter is mediated by NF-k binding motifs. EMBO J 9: 4435–4442PubMedGoogle Scholar
  185. Wilson-Rawls J, Wold WSM (1993) The E3–6.7K protein of adenovirus is an Asn-linked integral membrane glycoprotein localized in the endoplasmic reticulum. Virology 195: 6–15PubMedGoogle Scholar
  186. Wilson-Rawls J, Saha SK, Krajcsi P, Tollefson AE, Gooding LR, Wold WSM (1990) A 6700 MW membrane protein is encoded by region E3 of adenovirus type 2. Virology 178: 204–212PubMedGoogle Scholar
  187. Wilson-Rawls J, Deutscher SL, Wold WSM (1994) The signal-anchor domain of adenovirus E3–6.7K, a type III integral membrane protein, can direct adenovirus E3-gp19K, a type I integral membrane protein, into the membrane of the endoplasmic reticulum. Virology 201: 66–76PubMedGoogle Scholar
  188. Wold WSM (1993) Adenovirus genes that modulate the sensitivity of virus-infected cells to lysis by TNF. J Cell Biochem 53: 329–335PubMedGoogle Scholar
  189. Wold WSM, Gooding LR (1989) Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor. Mol Biol Med 6: 433–452PubMedGoogle Scholar
  190. Wold WSM, Gooding LR (1991) Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184: 1–8PubMedGoogle Scholar
  191. Wold WSM, Cladaras C, Magie SC, Yacoub N (1984) Mapping a new gene that encodes an 11,600-molecular-weight protein in the E3 transcription unit of adenovirus 2. J Virol 52: 307–313PubMedGoogle Scholar
  192. Wold WSM, Cladaras C, Deutscher SL, Kapoor QS (1985) The 19-kDa glycoprotein coded by region E3 of adenovirus: Purification, characterization, and structural analysis. J Biol Chem 260: 2424–2431PubMedGoogle Scholar
  193. Wold WSM, Deutscher SL, Takemori N, Bhat BM, Magie SC (1986) Evidence that AGUAUAUGA and CCAAGAUGA initiate translation in the same mRNA in region E3 of adenovirus. Virology 148: 168–180PubMedGoogle Scholar
  194. Wong GHW, Goeddel DV (1986) Tumour necrosis factors a and ß inhibit virus replication and synergize with interferons. Nature 323: 819–822PubMedGoogle Scholar
  195. Yewdell JW, Bennink JR, Eager KB, Ricciardi RP (1988) CTL recognition of adenovirus-transformed cells infected with influenza virus: lysis by anti-influenza CTL parallels adenovirus-12-induced suppression of class I MHC molecules. Virology 162: 236–238PubMedGoogle Scholar
  196. Zilli D, Voelkel-Johnson C, Skinner T, Laster SM (1992) The adenovirus E3 region 14.7 kDa protein, heat and sodium arsenite inhibit the TNF-induced release of arachidonic acid. Biochem Biophys Res Commun 188: 177–183PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • W. S. M. Wold
    • 1
  • A. E. Tollefson
    • 1
  • T. W. Hermiston
    • 1
  1. 1.Department of Molecular Microbiology and ImmunologySt. Louis University School of MedicineSt. LouisUSA

Personalised recommendations